z-basivarsen | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

637 results for “z-basivarsen”

Trials

View all 226 →

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

150 participants · First posted Mar 23, 2026

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

38 participants · First posted May 22, 2015

Not yet recruiting

PACTR201504001092179

202091 (EBOLA Z CHAD3-005)

3,000 participants

Drugs

View all 235 →

Z-338 Z-338

Z-11410

Z-1054

Organizations

View all 28 →

E-Z-EM, Inc.

United States

Alam, Dr Z Yasim

Canada

BIOVICO SP Z O O

Poland

News

View all 148 →

Dyne Therapeutics Reports Sustained One-Year Functional Improvements with Zeleciment Basivarsen in Myotonic Dystrophy Type 1

Novartis' Del-desiran Misses Primary Endpoint in Phase 3 HARBOR, Rattling DMPK-Targeting Field

UnitedHealthcare to Require DEX Z-Codes for Molecular Diagnostic Tests in Phase 3

Page 1 of 64